RecruitingNCT03029325
Molecular and Genetic Analysis of Lung Cancer
Sponsor
Massachusetts General Hospital
Enrollment
15,000 participants
Start Date
Jun 1, 1993
Study Type
OBSERVATIONAL
Conditions
Summary
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- healthy controls: participants without evidence of any cancer
- cases: pathology proven primary lung cancer
Exclusion Criteria1
- younger than 18 years old
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03029325
Related Trials
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device
NCT062954971 location
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations